Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS)

NCT: NCT05231213 · COMPLETED

NCT IDNCT05231213
StatusCOMPLETED
Start Date2022-11-02
Completion2025-03-31
SponsorVA Office of Research and Development (FED)
First posted
Last updated

Brief Summary

Impaired executive function, such as impaired decision making and impulsivity, has been identified as an important contributor to the transition from suicidal ideation to suicide attempt. To address the epidemic of Veteran suicide in the United States, this study tests the feasibility, acceptability, and preliminary effectiveness of a five day transcranial direct current stimulation (tDCS) augmented executive functioning training intervention. This intervention is delivered to high suicide risk inpatients. The ultimate goal is to reduce future suicide events (ideation, attempts, deaths) and improve quality of life (e.g. social relationships, health resource utilization).

Frequently Asked Questions

What is Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS)?

Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS) is a clinical trial registered under NCT05231213. Current status: COMPLETED.

What is the status of NCT05231213?

The current status of NCT05231213 (Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS)) is: COMPLETED.

When did Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS) start?

Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS) started on 2022-11-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.